Ziad Hijazi
Researcher at Department of Medical Sciences; Cardiology
- E-mail:
- ziad.hijazi@uu.se
- Visiting address:
- Akademiska sjukhuset, Ingång 40, 5 tr
751 85 Uppsala - Postal address:
- Akademiska sjukhuset, Ingång 40, 5 tr
751 85 UPPSALA
Download contact information for Ziad Hijazi at Department of Medical Sciences; Cardiology
Short presentation
Associate Professor of Cardiology, Department of Medical Sciences, Uppsala University.
Focus on cardiovascular research, supervision, and education.
ziad.hijazi@uu.se
Keywords
- Atrial fibrillation
- Cardiovascular research
- Clinical trials
- Biomarker research
- Risk assessment
- Stroke prevention
- Precision medicine

Publications
Selection of publications
-
Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial Fibrillation
Part of Journal of the American College of Cardiology, 2025
-
Part of Circulation, p. 1837-1846, 2024
-
Part of Journal of the American College of Cardiology, p. 1528-1540, 2024
-
Part of Journal of the American Heart Association, 2024
- DOI for Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial
- Download full text (pdf) of Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial
-
Part of Europace, 2024
- DOI for Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference
- Download full text (pdf) of Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference
-
Neurofilament Light Chain and Risk of Stroke in Patients With Atrial Fibrillation
Part of Circulation, p. 1090-1100, 2024
-
Part of European Heart Journal - Quality of Care and Clinical Outcomes, p. 609-620, 2023
- DOI for Data standards for atrial fibrillation/flutter and catheter ablation: The European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)
- Download full text (pdf) of Data standards for atrial fibrillation/flutter and catheter ablation: The European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)
-
Part of Chinese Medical Journal, p. 2451-2458, 2023
- DOI for ABC-AF-Stroke score predicts thromboembolism in non-anticoagulated patients following successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry
- Download full text (pdf) of ABC-AF-Stroke score predicts thromboembolism in non-anticoagulated patients following successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry
-
Plasma angiopoietin-2 and its association with heart failure in patients with atrial fibrillation
Part of Europace, 2023
- DOI for Plasma angiopoietin-2 and its association with heart failure in patients with atrial fibrillation
- Download full text (pdf) of Plasma angiopoietin-2 and its association with heart failure in patients with atrial fibrillation
-
Part of Circulation, p. 1748-1757, 2023
-
Part of American Heart Journal, p. 132-136, 2023
-
Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation
Part of European Heart Journal, p. 1807-1814, 2023
-
Part of American Heart Journal, p. 55-63, 2023
- DOI for Individual net clinical outcome with oral anticoagulation in atrial fibrillation using the ABC-AF risk scores
- Download full text (pdf) of Individual net clinical outcome with oral anticoagulation in atrial fibrillation using the ABC-AF risk scores
-
Part of Circulation, p. 1056-1066, 2022
- DOI for Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study
- Download full text (pdf) of Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study
-
Part of Frontiers in Medicine, 2022
- DOI for The ABC-Stroke Score Refines Stroke Risk Stratification in Patients With Atrial Fibrillation at the Emergency Department
- Download full text (pdf) of The ABC-Stroke Score Refines Stroke Risk Stratification in Patients With Atrial Fibrillation at the Emergency Department
-
Part of European Heart Journal, p. 208-218, 2022
- DOI for Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation
- Download full text (pdf) of Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation
-
Part of Future Cardiology, p. 635-646, 2022
-
Part of American Heart Journal, p. 13-24, 2022
- DOI for Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model
- Download full text (pdf) of Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model
-
Part of Circulation, p. 242-255, 2022
-
Part of Circulation, p. 958-960, 2022
-
Risk markers of incident atrial fibrillation in patients with coronary heart disease
Part of American Heart Journal, p. 92-101, 2021
- DOI for Risk markers of incident atrial fibrillation in patients with coronary heart disease
- Download full text (pdf) of Risk markers of incident atrial fibrillation in patients with coronary heart disease
-
Part of Circulation, p. 1215-1223, 2021
-
Part of Circulation, p. 359-361, 2021
-
Part of Open heart, 2021
- DOI for Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas
- Download full text (pdf) of Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas
-
Part of Circulation, p. 1863-1873, 2021
-
Part of Cardiovascular Research, p. 2112-2123, 2021
- DOI for Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.
- Download full text (pdf) of Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.
-
Part of Journal of Thrombosis and Haemostasis, p. 2726-2737, 2021
- DOI for Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation.
- Download full text (pdf) of Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation.
-
Natriuretic peptides and incident atrial fibrillation
Part of American Heart Journal, p. 1-1, 2021
-
Biomarker-based risk scores in atrial fibrillation
Part of European Heart Journal, p. 1084-1085, 2021
-
Part of JAMA Network Open, 2020
-
Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease
Part of Circulation, p. 1384-1392, 2020
-
Part of Journal of Thrombosis and Haemostasis, p. 2287-2295, 2020
- DOI for Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials.
- Download full text (pdf) of Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials.
-
Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation
Part of Journal of the American Heart Association, 2020
- DOI for Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation
- Download full text (pdf) of Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation
-
Part of Journal of the American Heart Association, 2020
-
Part of International Journal of Cardiology, p. 53-58, 2020
-
Part of European Heart Journal, p. 2848-2859, 2020
-
Part of Journal of Internal Medicine, p. 248-259, 2020
- DOI for Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial
- Download full text (pdf) of Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial
-
Part of Europace, p. 24-32, 2020
- DOI for Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: the STROKESTOP II study
- Download full text (pdf) of Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: the STROKESTOP II study
-
Part of European Heart Journal, p. 4037-4046, 2020
-
Part of Journal of the American Heart Association, 2019
- DOI for Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE-LY Trial
- Download full text (pdf) of Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE-LY Trial
-
Risk of ischemic stroke and utility of CHA2DS2-VASc score in women and men with atrial fibrillation
Part of Clinical Cardiology, p. 1003-1009, 2019
- DOI for Risk of ischemic stroke and utility of CHA2DS2-VASc score in women and men with atrial fibrillation
- Download full text (pdf) of Risk of ischemic stroke and utility of CHA2DS2-VASc score in women and men with atrial fibrillation
-
Part of Journal of Thrombosis and Thrombolysis, p. 27-34, 2019
-
Part of Circulation, p. 2292-2300, 2019
-
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
Part of New England Journal of Medicine, p. 1509-1524, 2019
-
Part of American Heart Journal, p. 123-131, 2019
-
Part of Heart, p. 353-354, 2019
-
Part of Open heart, 2018
- DOI for Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
- Download full text (pdf) of Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
-
Part of Journal of the American Heart Association, 2018
-
Part of American Heart Journal, p. 169-177, 2018
-
Part of Journal of the American College of Cardiology, p. 506-506, 2018
-
Part of Journal of the American College of Cardiology, p. 330-330, 2018
-
Part of Circulation, p. 1666-1676, 2018
-
Part of European Heart Journal, p. 477-485, 2018
- DOI for A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score
- Download full text (pdf) of A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score
-
The Science of Prognosis in Psychiatry: A Review
Part of JAMA psychiatry, p. 1289-1297, 2018
-
Part of Journal of Internal Medicine, p. 282-292, 2018
-
Part of Journal of the American Heart Association, 2017
-
Part of American Heart Journal, p. 94-103, 2017
-
Part of Trials, 2017
- DOI for Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial
- Download full text (pdf) of Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial
-
N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation
Part of Heart, p. 1271-1277, 2017
-
Application of Biomarkers for Risk Stratification in Patients with Atrial Fibrillation
Part of Clinical Chemistry, p. 152-164, 2017
-
Part of Journal of the American College of Cardiology, p. 327-327, 2017
-
The ABC risk score for patients with atrial fibrillation Reply
Part of The Lancet, p. 1980-1981, 2016
-
External Validation Of The Biomarker-Based ABC-Bleeding Risk Score For Atrial Fibrillation
Part of Journal of the American College of Cardiology, p. 893-893, 2016
-
Part of Heart, p. 508-517, 2016
-
Part of EUROPEAN HEART JOURNAL, p. 47-47, 2016
-
Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation
Part of Circulation, p. 1697-1707, 2016
-
Renal Function in Atrial Fibrillation A Multifaceted Dilemma
Part of Circulation, p. 48-51, 2016
-
External Validation Of The Biomarker-Based ABC-Stroke Risk Score For Atrial Fibrillation
Part of Journal of the American College of Cardiology, p. 879-879, 2016
-
Part of JAMA cardiology, p. 673-681, 2016
-
p. 429-429, 2016
-
Part of European Heart Journal, p. 2869-2878, 2016
-
Part of International Journal of Cardiology, p. 74-81, 2016
-
Part of JAMA cardiology, p. 451-460, 2016
-
Part of European Heart Journal, p. 1582-1590, 2016
-
Part of The Lancet, p. 2302-2311, 2016
-
Part of European Heart Journal, p. 339-339, 2015
-
External validation of the biomarker-based ABC-stroke risk score for atrial fibrillation
Part of European Heart Journal, p. 710-711, 2015
-
Changes in Renal Function in Patients With Atrial Fibrillation An Analysis From the RE-LY Trial
Part of Journal of the American College of Cardiology, p. 2481-2493, 2015
-
Part of Clinical Chemistry, p. 368-378, 2015
-
Stora studier av NOAK visar på gott och säkert strokeskydd
Part of Läkartidningen, 2015
-
Reply: Anticoagulant-Related Nephropathy
Part of Journal of the American College of Cardiology, p. 2682, 2015
-
Part of European Heart Journal, p. 345-345, 2015
-
Part of American Heart Journal, p. 1151-1160, 2015
-
Part of Journal of the American College of Cardiology, p. 52-61, 2014
-
Part of Circulation, p. 1847-1858, 2014
-
Part of European Heart Journal, p. 1115-1116, 2014
-
Part of European Heart Journal, p. 357-357, 2014
-
Part of Läkartidningen, p. 872-874, 2014
-
Importance of Persistent Elevation of Cardiac Biomarkers in Atrial Fibrillation: a RE-LY Substudy
Part of Heart, p. 1193-1200, 2014
-
Part of Circulation, p. 961-970, 2014
-
Part of Circulation, 2014
-
Part of European Heart Journal, p. 426-426, 2014
-
Part of Circulation, p. 625-634, 2014
-
New Risk Markers in Atrial Fibrillation
2013
-
Part of Journal of the American College of Cardiology, p. 2274-2284, 2013
-
Biomarkers in atrial fibrillation: a clinical review
Part of European Heart Journal, p. 1475-1480, 2013
-
Reply: Higher N-Terminal Pro-B-Type Natriuretic Peptide May Be Related to Very Different Conditions
Part of Journal of the American College of Cardiology, p. 1635-1636, 2013
-
Part of Circulation, 2013
-
Part of Circulation, 2013
-
Part of Circulation, p. 1605-1616, 2012
-
Part of European Heart Journal, p. 2821-2830, 2012
-
Recent publications
-
Part of Heart, 2026
- DOI for NT-proBNP in relation to clinical characteristics and cardiovascular outcomes in non-anticoagulated patients with atrial fibrillation
- Download full text (pdf) of NT-proBNP in relation to clinical characteristics and cardiovascular outcomes in non-anticoagulated patients with atrial fibrillation
-
DOAC score among patients receiving Vitamin K antagonists
Part of American Heart Journal, 2026
-
Multi-cohort proteogenomic analyses reveal genetic effects across the proteome and diseasome
Part of Cell, p. 3339-+, 2026
- DOI for Multi-cohort proteogenomic analyses reveal genetic effects across the proteome and diseasome
-
Part of Heart, p. 761-770, 2026
- DOI for Risk and protective factors for stroke and transient ischaemic attack in patients with atrial fibrillation: an umbrella review of meta-analyses
- Download full text (pdf) of Risk and protective factors for stroke and transient ischaemic attack in patients with atrial fibrillation: an umbrella review of meta-analyses
-
Part of European Stroke Journal, 2026
- DOI for Early versus delayed DOAC after ischaemic stroke in atrial fibrillation: 1-year outcomes in the TIMING study and in concurrent practice
- Download full text (pdf) of Early versus delayed DOAC after ischaemic stroke in atrial fibrillation: 1-year outcomes in the TIMING study and in concurrent practice
All publications
Articles in journal
-
Part of Heart, 2026
- DOI for NT-proBNP in relation to clinical characteristics and cardiovascular outcomes in non-anticoagulated patients with atrial fibrillation
- Download full text (pdf) of NT-proBNP in relation to clinical characteristics and cardiovascular outcomes in non-anticoagulated patients with atrial fibrillation
-
DOAC score among patients receiving Vitamin K antagonists
Part of American Heart Journal, 2026
-
Multi-cohort proteogenomic analyses reveal genetic effects across the proteome and diseasome
Part of Cell, p. 3339-+, 2026
- DOI for Multi-cohort proteogenomic analyses reveal genetic effects across the proteome and diseasome
-
Part of Heart, p. 761-770, 2026
- DOI for Risk and protective factors for stroke and transient ischaemic attack in patients with atrial fibrillation: an umbrella review of meta-analyses
- Download full text (pdf) of Risk and protective factors for stroke and transient ischaemic attack in patients with atrial fibrillation: an umbrella review of meta-analyses
-
Part of European Stroke Journal, 2026
- DOI for Early versus delayed DOAC after ischaemic stroke in atrial fibrillation: 1-year outcomes in the TIMING study and in concurrent practice
- Download full text (pdf) of Early versus delayed DOAC after ischaemic stroke in atrial fibrillation: 1-year outcomes in the TIMING study and in concurrent practice
-
Part of Journal of Thrombosis and Haemostasis, p. 399-407, 2026
- DOI for Evaluation of the updated ABC-AF-bleeding score 2.0 in patients with atrial fibrillation treated with a direct oral anticoagulant or warfarin
- Download full text (pdf) of Evaluation of the updated ABC-AF-bleeding score 2.0 in patients with atrial fibrillation treated with a direct oral anticoagulant or warfarin
-
Part of Journal of the American Heart Association, 2026
- DOI for Plasma Biomarkers Associated With Heart Failure Hospitalization Among Patients With Atrial Fibrillation and Subtypes of Heart Failure
- Download full text (pdf) of Plasma Biomarkers Associated With Heart Failure Hospitalization Among Patients With Atrial Fibrillation and Subtypes of Heart Failure
-
Part of European Heart Journal Open, 2025
- DOI for Differences in inflammation biomarkers between patients with paroxysmal and persistent atrial fibrillation in the femoral vein and coronary sinus blood samples: a cohort study
- Download full text (pdf) of Differences in inflammation biomarkers between patients with paroxysmal and persistent atrial fibrillation in the femoral vein and coronary sinus blood samples: a cohort study
-
Part of Europace, 2025
- DOI for Transforming Atrial Fibrillation Management by Targeting Comorbidities and Reducing Atrial Fibrillation Burden: the 10th AFNET/EHRA Consensus Conference
- Download full text (pdf) of Transforming Atrial Fibrillation Management by Targeting Comorbidities and Reducing Atrial Fibrillation Burden: the 10th AFNET/EHRA Consensus Conference
-
Part of Circulation, p. 1457-1469, 2025
- DOI for Biomarker-Based ABC-AF Risk Scores for Personalized Treatment to Reduce Stroke or Death in Atrial Fibrillation: A Registry-Based, Multicenter, Randomized, Controlled Study
- Download full text (pdf) of Biomarker-Based ABC-AF Risk Scores for Personalized Treatment to Reduce Stroke or Death in Atrial Fibrillation: A Registry-Based, Multicenter, Randomized, Controlled Study
-
Part of American Heart Journal, p. 161-169, 2025
- DOI for Rationale and design of a registry-based randomized controlled study of personalized biomarker-based risk score-guided stroke prevention treatment in atrial fibrillation
- Download full text (pdf) of Rationale and design of a registry-based randomized controlled study of personalized biomarker-based risk score-guided stroke prevention treatment in atrial fibrillation
-
Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial Fibrillation
Part of Journal of the American College of Cardiology, 2025
-
Part of Circulation, p. 1837-1846, 2024
-
Part of Journal of the American College of Cardiology, p. 1528-1540, 2024
-
Part of Journal of the American Heart Association, 2024
- DOI for Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial
- Download full text (pdf) of Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial
-
Part of Europace, 2024
- DOI for Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference
- Download full text (pdf) of Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference
-
Neurofilament Light Chain and Risk of Stroke in Patients With Atrial Fibrillation
Part of Circulation, p. 1090-1100, 2024
-
Part of European Heart Journal - Quality of Care and Clinical Outcomes, p. 609-620, 2023
- DOI for Data standards for atrial fibrillation/flutter and catheter ablation: The European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)
- Download full text (pdf) of Data standards for atrial fibrillation/flutter and catheter ablation: The European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)
-
Part of Chinese Medical Journal, p. 2451-2458, 2023
- DOI for ABC-AF-Stroke score predicts thromboembolism in non-anticoagulated patients following successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry
- Download full text (pdf) of ABC-AF-Stroke score predicts thromboembolism in non-anticoagulated patients following successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry
-
Plasma angiopoietin-2 and its association with heart failure in patients with atrial fibrillation
Part of Europace, 2023
- DOI for Plasma angiopoietin-2 and its association with heart failure in patients with atrial fibrillation
- Download full text (pdf) of Plasma angiopoietin-2 and its association with heart failure in patients with atrial fibrillation
-
Part of Circulation, p. 1748-1757, 2023
-
Part of American Heart Journal, p. 132-136, 2023
-
Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation
Part of European Heart Journal, p. 1807-1814, 2023
-
Part of American Heart Journal, p. 55-63, 2023
- DOI for Individual net clinical outcome with oral anticoagulation in atrial fibrillation using the ABC-AF risk scores
- Download full text (pdf) of Individual net clinical outcome with oral anticoagulation in atrial fibrillation using the ABC-AF risk scores
-
Part of Circulation, p. 1056-1066, 2022
- DOI for Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study
- Download full text (pdf) of Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study
-
Part of Frontiers in Medicine, 2022
- DOI for The ABC-Stroke Score Refines Stroke Risk Stratification in Patients With Atrial Fibrillation at the Emergency Department
- Download full text (pdf) of The ABC-Stroke Score Refines Stroke Risk Stratification in Patients With Atrial Fibrillation at the Emergency Department
-
Part of European Heart Journal, p. 208-218, 2022
- DOI for Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation
- Download full text (pdf) of Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation
-
Part of Future Cardiology, p. 635-646, 2022
-
Part of American Heart Journal, p. 13-24, 2022
- DOI for Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model
- Download full text (pdf) of Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model
-
Part of Circulation, p. 242-255, 2022
-
Part of Circulation, p. 958-960, 2022
-
Risk markers of incident atrial fibrillation in patients with coronary heart disease
Part of American Heart Journal, p. 92-101, 2021
- DOI for Risk markers of incident atrial fibrillation in patients with coronary heart disease
- Download full text (pdf) of Risk markers of incident atrial fibrillation in patients with coronary heart disease
-
Part of Circulation, p. 1215-1223, 2021
-
Part of Circulation, p. 359-361, 2021
-
Part of Open heart, 2021
- DOI for Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas
- Download full text (pdf) of Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas
-
Part of Circulation, p. 1863-1873, 2021
-
Part of Cardiovascular Research, p. 2112-2123, 2021
- DOI for Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.
- Download full text (pdf) of Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.
-
Part of Journal of Thrombosis and Haemostasis, p. 2726-2737, 2021
- DOI for Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation.
- Download full text (pdf) of Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation.
-
Natriuretic peptides and incident atrial fibrillation
Part of American Heart Journal, p. 1-1, 2021
-
Biomarker-based risk scores in atrial fibrillation
Part of European Heart Journal, p. 1084-1085, 2021
-
Part of JAMA Network Open, 2020
-
Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease
Part of Circulation, p. 1384-1392, 2020
-
Part of Journal of Thrombosis and Haemostasis, p. 2287-2295, 2020
- DOI for Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials.
- Download full text (pdf) of Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials.
-
Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation
Part of Journal of the American Heart Association, 2020
- DOI for Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation
- Download full text (pdf) of Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation
-
Part of Journal of the American Heart Association, 2020
-
Part of International Journal of Cardiology, p. 53-58, 2020
-
Part of European Heart Journal, p. 2848-2859, 2020
-
Part of Journal of Internal Medicine, p. 248-259, 2020
- DOI for Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial
- Download full text (pdf) of Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial
-
Part of Europace, p. 24-32, 2020
- DOI for Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: the STROKESTOP II study
- Download full text (pdf) of Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: the STROKESTOP II study
-
Part of European Heart Journal, p. 4037-4046, 2020
-
Part of Journal of the American Heart Association, 2019
- DOI for Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE-LY Trial
- Download full text (pdf) of Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE-LY Trial
-
Risk of ischemic stroke and utility of CHA2DS2-VASc score in women and men with atrial fibrillation
Part of Clinical Cardiology, p. 1003-1009, 2019
- DOI for Risk of ischemic stroke and utility of CHA2DS2-VASc score in women and men with atrial fibrillation
- Download full text (pdf) of Risk of ischemic stroke and utility of CHA2DS2-VASc score in women and men with atrial fibrillation
-
Part of Journal of Thrombosis and Thrombolysis, p. 27-34, 2019
-
Part of Circulation, p. 2292-2300, 2019
-
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
Part of New England Journal of Medicine, p. 1509-1524, 2019
-
Part of American Heart Journal, p. 123-131, 2019
-
Part of Heart, p. 353-354, 2019
-
Part of Open heart, 2018
- DOI for Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
- Download full text (pdf) of Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
-
Part of Journal of the American Heart Association, 2018
-
Part of American Heart Journal, p. 169-177, 2018
-
Part of Journal of the American College of Cardiology, p. 506-506, 2018
-
Part of Journal of the American College of Cardiology, p. 330-330, 2018
-
Part of Circulation, p. 1666-1676, 2018
-
Part of European Heart Journal, p. 477-485, 2018
- DOI for A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score
- Download full text (pdf) of A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score
-
Part of Journal of Internal Medicine, p. 282-292, 2018
-
Part of Journal of the American Heart Association, 2017
-
Part of American Heart Journal, p. 94-103, 2017
-
Part of Trials, 2017
- DOI for Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial
- Download full text (pdf) of Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial
-
N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation
Part of Heart, p. 1271-1277, 2017
-
Part of Journal of the American College of Cardiology, p. 327-327, 2017
-
The ABC risk score for patients with atrial fibrillation Reply
Part of The Lancet, p. 1980-1981, 2016
-
External Validation Of The Biomarker-Based ABC-Bleeding Risk Score For Atrial Fibrillation
Part of Journal of the American College of Cardiology, p. 893-893, 2016
-
Part of Heart, p. 508-517, 2016
-
Part of EUROPEAN HEART JOURNAL, p. 47-47, 2016
-
Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation
Part of Circulation, p. 1697-1707, 2016
-
Renal Function in Atrial Fibrillation A Multifaceted Dilemma
Part of Circulation, p. 48-51, 2016
-
External Validation Of The Biomarker-Based ABC-Stroke Risk Score For Atrial Fibrillation
Part of Journal of the American College of Cardiology, p. 879-879, 2016
-
Part of JAMA cardiology, p. 673-681, 2016
-
Part of European Heart Journal, p. 2869-2878, 2016
-
Part of International Journal of Cardiology, p. 74-81, 2016
-
Part of JAMA cardiology, p. 451-460, 2016
-
Part of European Heart Journal, p. 1582-1590, 2016
-
Part of The Lancet, p. 2302-2311, 2016
-
Part of European Heart Journal, p. 339-339, 2015
-
External validation of the biomarker-based ABC-stroke risk score for atrial fibrillation
Part of European Heart Journal, p. 710-711, 2015
-
Changes in Renal Function in Patients With Atrial Fibrillation An Analysis From the RE-LY Trial
Part of Journal of the American College of Cardiology, p. 2481-2493, 2015
-
Part of Clinical Chemistry, p. 368-378, 2015
-
Reply: Anticoagulant-Related Nephropathy
Part of Journal of the American College of Cardiology, p. 2682, 2015
-
Part of European Heart Journal, p. 345-345, 2015
-
Part of American Heart Journal, p. 1151-1160, 2015
-
Part of Journal of the American College of Cardiology, p. 52-61, 2014
-
Part of Circulation, p. 1847-1858, 2014
-
Part of European Heart Journal, p. 1115-1116, 2014
-
Part of European Heart Journal, p. 357-357, 2014
-
Part of Läkartidningen, p. 872-874, 2014
-
Importance of Persistent Elevation of Cardiac Biomarkers in Atrial Fibrillation: a RE-LY Substudy
Part of Heart, p. 1193-1200, 2014
-
Part of Circulation, p. 961-970, 2014
-
Part of Circulation, 2014
-
Part of European Heart Journal, p. 426-426, 2014
-
Part of Circulation, p. 625-634, 2014
-
Part of Journal of the American College of Cardiology, p. 2274-2284, 2013
-
Biomarkers in atrial fibrillation: a clinical review
Part of European Heart Journal, p. 1475-1480, 2013
-
Reply: Higher N-Terminal Pro-B-Type Natriuretic Peptide May Be Related to Very Different Conditions
Part of Journal of the American College of Cardiology, p. 1635-1636, 2013
-
Part of Circulation, 2013
-
Part of Circulation, 2013
-
Part of Circulation, p. 1605-1616, 2012
-
Part of European Heart Journal, p. 2821-2830, 2012
Articles, review/survey
-
Part of The Lancet, p. 43-51, 2025
- DOI for Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST)
- Download full text (pdf) of Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST)
-
The Science of Prognosis in Psychiatry: A Review
Part of JAMA psychiatry, p. 1289-1297, 2018
-
Application of Biomarkers for Risk Stratification in Patients with Atrial Fibrillation
Part of Clinical Chemistry, p. 152-164, 2017
-
Stora studier av NOAK visar på gott och säkert strokeskydd
Part of Läkartidningen, 2015